missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30291493

M-CSFR/CD115 Antibody (CL11653) [DyLight 350], Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP3-21198UV

Product Code. 30291493

  • 737.00 € / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

M-CSFR/CD115 Monoclonal antibody specifically detects M-CSFR/CD115 in Human samples. It is validated for Immunocytochemistry/ Immunofluorescence
TRUSTED_SUSTAINABILITY
Specifications

Specifications

M-CSFR/CD115
Monoclonal
DyLight 350
CD115, CD115 antigen, C-FMS, colony stimulating factor 1 receptor, CSF-1-R, CSFR, EC 2.7.10.1, FMS proto-oncogene, FMSFIM2, macrophage colony stimulating factor I receptor, macrophage colony-stimulating factor 1 receptor, McDonough feline sarcoma viral (v-fms) oncogene homolog, Proto-oncogene c-Fms
This antibody was developed using a recombinant protein derived from P07333, with the exact immunogen sequence remaining proprietary.
0.1 mL
Myeloid derived Suppressor Cell, Phospho Specific, Protein Kinase
1436
Store at 4⪚C in the dark.
IgG1
Immunocytochemistry/Immunofluorescence
CL11653
50mM Sodium Borate
Mouse
Protein A purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.